Wiebke Sihver

Synthesis and Evaluation of No-Carrier-Added 8-Cyclopentyl-3-(3-[¹⁸F]fluoropropyl)-1-propylxanthine ([¹⁸F]CPFPX):  A Potent and Selective A₁-Adenosine Receptor Antagonist for in Vivo Imaging

M. Holschbach, Ray A. Olsson, Dirk Bier et al. · Journal of Medicinal Chemistry · 2002 · 80 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy

Wiebke Sihver, Jens Pietzsch, Mechthild Krause et al. · Pharmaceuticals · 2014 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography

Wiebke Sihver, Per‐Göran Gillberg, Agneta Nordberg · Neuroscience · 1998 · 58 citations

Life Sciences, Neuroscience, Pharmacology +13

Autoradiographic comparison of [3H](−)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease

Wiebke Sihver, P.-G. Gillberg, Anne Svensson et al. · Neuroscience · 1999 · 55 citations

Life Sciences, Neurobiology, Neuroscience +16

Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: A detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788

Wiebke Sihver, Sven Sihver, Mats Bergström et al. · Nuclear Medicine and Biology · 1997 · 41 citations

Medicine, Medicinal Chemistry, Pharmacology +17